Job Market Sluggish For Neuroscientists

Despite advances in brain research, career horizons remain foggy for the researchersAs the Society for Neuroscience convenes its 22nd annual meeting in Anaheim, Calif., this month, researchers will share a wealth of new knowledge about the central nervous system--about, for example, the uses of monoclonal antibody technology in studying the brain and the cognitive consequences of aging. But, as in other scientific disciplines, neuroscience research gains have not translated easily into achi

Written byMarcia Clemmitt
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

But, as in other scientific disciplines, neuroscience research gains have not translated easily into achievements in the job market, especially in academia, observers of the field say.

The recent reorganization of the National Institutes of Health to include the National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under its auspices--instead of as three divisions of the separate and now- disbanded Alcohol, Drug Abuse, and Mental Health Administration-- will not threaten funding for basic neuroscience research, according to NIMH director Frederick Goodwin. In fact, Goodwin says, he hopes the change may foster more of the kind of cross- disciplinary research brain science increasingly demands. "The legislation [authorizing the changes] specifically prohibits any merging of programs," Goodwin says. "That no-merging provision should allay concerns people have about our creating some kind of `super brain institute' that would ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies